Business Context and Reporting Period
Company: Horace Mann Educators Corporation (HMN)
Filing Type: Form 8-K (Current Report)
Date of Report: July 21, 2026
Principal Activity: Entry into a Material Definitive Agreement to acquire Reserve National Insurance Company (RNIC) and execute a reinsurance transaction with Medical Mutual of Ohio (MMO) and Medical Mutual Life Insurance Company (MML).
Key Financial Metrics and Transaction Details
This filing details a specific acquisition transaction rather than periodic financial performance. Key financial figures related to the transaction include:
- Total Purchase Price for RNIC: Approximately $125 million.
- Excess Statutory Capital: Approximately $10 million expected to remain in RNIC at closing.
- Ceding Commission: Approximately $7.4 million payable to MML for the Reinsurance Transaction.
- Funding Source: Cash on hand and borrowings under the Company's existing credit facility.
- Excluded Assets: Existing Medicare supplement insurance policies of RNIC will be excluded and reinsured or transferred prior to closing.
Note: The filing does not provide current period revenue, profit, cash flow, margins, or total debt figures. These metrics are not applicable to this specific 8-K transaction report.
Material Changes and Transaction Structure
The Company entered into a Master Transaction Agreement on July 21, 2026, comprising two main components:
- Stock Purchase: Acquisition of all issued and outstanding shares of RNIC.
- Reinsurance Transaction: MML will reinsure substantially all in-force insurance policies to an affiliate of Horace Mann.
The transaction has been approved by the Company's Board of Directors. Closing is expected in the first quarter of 2027, subject to regulatory approvals and satisfaction of closing conditions.
Outlook, Risks, and Management Commentary
Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking information, noting that actual results could differ materially from projections due to known and unknown risks. The Company disclaims any obligation to update these statements.
Contingencies: The closing of the acquisition is contingent upon:
- Satisfaction or waiver of applicable closing conditions.
- Approval by certain regulators.
Future Filings: A full copy of the Master Transaction Agreement will be filed in the Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2026.
Investor Verification Checklist
- Verify the final closing date, as it is currently projected for Q1 2027.
- Confirm regulatory approval status for the acquisition of RNIC and the reinsurance transaction.
- Review the upcoming Form 10-Q (Q3 2026) for the full text of the Master Transaction Agreement.
- Monitor the Company's credit facility usage to fund the $125 million purchase price and $7.4 million commission.
- Assess the impact of excluding RNIC's Medicare supplement policies on the overall asset quality of the acquisition.